Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells (vol 24, pg 282, 2018)

Cancer and Leukemia Group B

Research output: Contribution to journalArticlepeer-review

5 Scopus citations
Original languageEnglish
Pages (from-to)526-526
JournalNature Medicine
Issue number4
StatePublished - Apr 2018

PubMed: MeSH publication types

  • Published Erratum

Cite this